Nov 23, 2022
Australia and Oceania
The article provides an overview of the regulatory requirements related to handling post-approval studies. Table of Contents The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere of healthcare products, has published a...
Read More
Nov 23, 2022
Australia and Oceania
The new article highlights the most important aspects related to the application of the least burdensome approach for deficiencies arising from the issues identified by the authority when reviewing the application for marketing approval. Table of Contents The Food...
Read More
Nov 17, 2022
Australia and Oceania
The article provides an overview of the policy suggested for deficiencies in medical devices. Table of Contents The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere of healthcare products, has published a guidance document...
Read More
Nov 17, 2022
Australia and Oceania
The new article highlights the key points related to clinical outcome studies that are not using concurrent (or historical) controls. Table of Contents The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere of healthcare...
Read More
Nov 10, 2022
Australia and Oceania
The new article describes in detail the aspects related to the clinical evidence required for meshes, patches, and tissue adhesives. Table of Contents The Therapeutic Goods Administration (TGA), an Australian regulating authority in the sphere of healthcare products,...
Read More